In the work described here, the pharmaceutical formulation used to achieve oral delivery, Axcess- comprising a combination of chenodeoxycholate and propyl gallate as absorption enhancers, is one which has already been employed successfully in humans to achieve delivery of insulin in a safe, efficacious and commercially viable manner
The third and fourth groups were co-administered DEX with SPAE at 400 mg/kg and 800 mg/kg body weight/day orally for the same period
Medication labels will indicate concentration, often expressed as mg/mL
In older adults, that can translate into weakness, falls, and loss of independence if they are not protecting muscle with protein and resistance work
These may support memory, attention, and mental clarity